Ultravalue Pharmaceuticals Private Limited
About Ultravalue Pharmaceuticals Private Limited
Data last updated:
Ultravalue Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 June 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51900UP2022PTC165514.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It was formerly known as Puralma Pharmaceuticals Private Limited. It is led by directors including Mahesh Prasad Singh and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Basement 26/11 Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.75 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹11.43 Lakh (net margin 1.2%) and EBITDA of ₹16.86 Lakh (EBITDA margin 1.7%).
The company has about 75 employees on its provident fund (EPFO) records.
Company details
Contact details
Ultravalue Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressBasement 26/11 Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, India – 226001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ultravalue Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ultravalue Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ultravalue Pharmaceuticals Private Limited, buy the company report.
Financials of Ultravalue Pharmaceuticals Private Limited
FY 2024 filings availableUltravalue Pharmaceuticals Private Limited reported revenue of ₹9.75 Cr (up 578% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 578% in the latest year. EBITDA rose 362% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹16.86 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹11.43 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.7% | |
| Net Profit Margin | 1.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ultravalue Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ultravalue Pharmaceuticals Private Limited
Ultravalue Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Prasad Singh | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Rakesh Kumar | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Purshottam Kant Bajpai Also directs: Value Formulations Private Limited, Valuemoney Nidhi Limited | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Lalan Singh | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Amit Kumar Anit | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Ultravalue Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Concur Pharmaceuticals Private Limited | ₹9.98 Cr (FY 2024) | 17.0% | Delhi, India | |||
| Ventus Pharmaceuticals Private Limited | ₹9.89 Cr (FY 2025) | 12.0% | Panchkula, Haryana, India | |||
| Ultravalue Pharmaceuticals Private Limitedthis company | ₹9.75 Cr (FY 2024) | ₹11.43 Lakh | 1.2% | 578.0% | 75 | Lucknow, Uttar Pradesh, India |
| Shree Radhey Gobind International Pharmaceuticals Private Limited | ₹9.73 Cr (FY 2025) | 11.0% | Delhi, India |
To see the full peer comparison of Ultravalue Pharmaceuticals Private Limited, buy the company report.
Auditor
Ultravalue Pharmaceuticals Private Limited is audited by SETH CHATURVEDI & JAIN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SETH CHATURVEDI & JAIN | FY 2023 | 004537C |
Legal cases
No court or tribunal cases involving Ultravalue Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ultravalue Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ultravalue Pharmaceuticals Private Limited has a workforce of 75 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Ultravalue Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ultravalue Pharmaceuticals Private Limited has 5 board changes on record since 2022: 5 appointments. The latest: Amit Kumar Anit was appointed as Director on 10 Jun 2022.
Frequently asked questions
Ultravalue Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 June 2022 (4+ years old) and is registered under CIN U51900UP2022PTC165514.
Ultravalue Pharmaceuticals has 5 current directors:
- Mahesh Prasad Singh - Director
- Rakesh Kumar - Director
- Purshottam Kant Bajpai - Director
- Lalan Singh - Director
- Amit Kumar Anit - Director
The latest financial statements of Ultravalue Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ultravalue Pharmaceuticals is U51900UP2022PTC165514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ultravalue Pharmaceuticals was incorporated on 10 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ultravalue Pharmaceuticals by revenue are Concur Pharmaceuticals Private Limited, Ventus Pharmaceuticals Private Limited, Shree Radhey Gobind International Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Kumar Anit was appointed as Director on 10 Jun 2022. Lalan Singh was appointed as Director on 10 Jun 2022. Mahesh Prasad Singh was appointed as Director on 10 Jun 2022. Ultravalue Pharmaceuticals has 5 board changes on record in total.
The registered office of Ultravalue Pharmaceuticals is at Basement 2611 Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, India – 226001.
Ultravalue Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Yes. Ultravalue Pharmaceuticals was formerly known as Puralma Pharmaceuticals Private Limited.
Ultravalue Pharmaceuticals can be reached at its registered office: Basement 2611 Radiant Apartment Wazir Hasan Road, Lucknow, Uttar Pradesh, India – 226001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
